
Halozyme Therapeutics HALO
$ 71.45
-0.04%
Quarterly report 2026-Q1
added 05-11-2026
Halozyme Therapeutics Total Inventories 2011-2026 | HALO
Annual Total Inventories Halozyme Therapeutics
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 176 M | 142 M | 128 M | 100 M | 53.9 M | 60.7 M | 29.4 M | 22.6 M | 5.15 M | 14.6 M | 9.49 M | 6.41 M | 6.17 M | 2.67 M | 567 K | 193 K | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 176 M | 193 K | 47.4 M |
Quarterly Total Inventories Halozyme Therapeutics
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 155 M | 186 M | 182 M | 165 M | 142 M | 131 M | 159 M | 169 M | 128 M | 129 M | 132 M | 108 M | 100 M | 103 M | 97.6 M | 47.8 M | 53.9 M | 56 M | 58.6 M | 58.3 M | 60.7 M | 60.7 M | 60.7 M | 60.7 M | 29.4 M | 29.4 M | 29.4 M | 29.4 M | 22.6 M | 22.6 M | 22.6 M | 22.6 M | 5.15 M | 5.15 M | 5.15 M | 5.15 M | 14.6 M | 14.6 M | 14.6 M | 14.6 M | 9.49 M | 9.49 M | 9.49 M | 9.49 M | 6.41 M | 6.41 M | 6.41 M | 6.41 M | 6.17 M | 6.17 M | 6.17 M | 6.17 M | 2.67 M | 2.67 M | 2.67 M | 2.67 M | 567 K | 567 K | 567 K | 567 K |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 186 M | 567 K | 49.9 M |
Total Inventories of other stocks in the Biotechnology industry
| Issuer | Total Inventories | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Happiness Biotech Group Limited
HAPP
|
653 K | - | 1.35 % | $ 17.8 M | ||
|
Deciphera Pharmaceuticals
DCPH
|
21.2 M | - | - | $ 2.18 B | ||
|
Coherus BioSciences
CHRS
|
3.17 M | $ 1.38 | -3.17 % | $ 162 M | ||
|
Berkeley Lights
BLI
|
18.9 M | - | -7.31 % | $ 87 M | ||
|
Esperion Therapeutics
ESPR
|
105 M | $ 3.15 | 0.16 % | $ 655 M | ||
|
Cyclacel Pharmaceuticals
CYCCP
|
1.38 M | - | -4.36 % | $ 27 M | ||
|
Eton Pharmaceuticals
ETON
|
15.4 M | $ 31.58 | 3.44 % | $ 850 M | ||
|
Exelixis
EXEL
|
21.7 M | $ 52.92 | -0.13 % | $ 14.4 B | ||
|
Anika Therapeutics
ANIK
|
18.8 M | $ 14.97 | 2.75 % | $ 215 M | ||
|
Albireo Pharma
ALBO
|
194 K | - | -0.23 % | $ 916 M |